BBK Worldwide Blog

Elizabeth Gargill

Recent Posts

Catch Up on Our Recent Content for Clinical Trial Sponsors

Posted by Elizabeth Gargill

Catch Up on Our Content for Clinical Trial Sponsors

Featuring insights from industry thought leaders, our content provides clinical trial sponsors with knowledge and guidance to help navigate today’s challenging clinical trial patient recruitment and engagement environment.

Read More

Topics: Patient Engagement, Patient Voice, Diversity, Inclusion, Gaby Grekin, Justin Jones, Hybrid, Equity, Podcast, DEI, Study Voices Survey

Podcast: The Key Role of Strategy and Media in Improving Clinical Trial Enrollment Diversity

Posted by Elizabeth Gargill


Hear From Our Experts on Improving Clinical Trial Enrollment Diversity

In our latest podcast, BBK's Justin Jones and Gaby Grekin discuss strategies and insights that clinical trial sponsors can leverage to make their studies more diverse and inclusive.  

Listen Now!
 
 
Read More

Topics: Media, Research, Diversity, Inclusion, Gaby Grekin, Strategy, Justin Jones, The Conference Forum, Equity, Podcast

HYBRID: A New Approach for Clinical Trial Recruitment & Engagement Success

Posted by Elizabeth Gargill

Introducing a New Approach to Clinical Trial Recruitment & Engagement

 

Our hybrid approach to clinical trial recruitment and engagement provides sponsors with the flexibility and agility they need whether they are conducting a traditional site-based trial, hybrid trial, or decentralized trial. 

Read More

Topics: TrialCentralNet, Decentralized Clinical Trials, Decentralized Solutions, Hybrid Clinical Trials, Hybrid, TCN

Facilitating the Journey from Patient to Study Participant

Posted by Elizabeth Gargill

Pharma15 Live!

Facilitating the Journey from Patient to Study Participant

The Impact of Dynamic Referral Processing

Matt Kibby and Aaron Fleishman return to the Pharma15 Live! stage to discuss BBK's dynamic referral processing service and how it improves and accelerates the patient enrollment process. 

"Our process benefits both patients and sites alike. It unburdens the study staff, creating a better experience for them, while also ensuring patients are responded to more quickly and with better care so their journey is a positive one."

-Matt Kibby, President, Chief Strategy Officer, BBK Worldwide

Watch Now

Read More

Topics: Pharma15 Live!, Call Centers, Matt Kibby, Aaron Fleishman, Hybrid Clinical Trials, Dynamic Referral Processing, Secondary Prescreening

Study Voices Survey: Patients want choice offered through hybrid enrollment solutions

Posted by Elizabeth Gargill

 

New survey findings reveal the importance of offering patients choice when it comes to improving clinical trial diversity, access, and engagement.

Patients want options, or choice, when it comes to clinical trial participation. New data from a recent Study Voices survey reveals the impact choice can have on participation. The findings empower clinical trial sponsors to shift from traditional clinical trial enrollment models to hybrid enrollment models.

 

DOWNLOAD NOW

Read More

Topics: Most Viewed, Study Voices, Aaron Fleishman, International Clinical Trials, Surveys, Hybrid Clinical Trials

2022: A Look into Our Crystal Ball

Posted by Elizabeth Gargill

 

The clinical trial landscape saw a lot of changes in 2021, from decentralized clinical trial adoption to a greater emphasis on diversity and inclusion. But what’s in store for 2022? We asked our industry experts to weigh in with their predictions.

Read More

Topics: Most Viewed, Aaron Fleishman, Mike Johnson, Danielle Frate, Dena Raffa, 2022 Predictions, Justin Jones, Crystal Ball

Survey: Patients Want Choice Offered through Hybrid Clinical Trials

Posted by Elizabeth Gargill

New survey results and insights help clinical trial sponsors improve diversity and inclusion, enroll faster, and keep participants engaged longer.

When we developed our latest Study Voices survey, we expected to see large gaps in attitudes and experiences among healthcare consumers and clinical trial participants based on factors such as age, race, ethnicity, gender, and income – but that wasn’t the case.

Read More

Topics: Patient Engagement, Study Voices, Surveys, Diversity, Inclusion, Patients, Hybrid Clinical Trials, Whitepaper

Catch Up on Our Content for Clinical Trial Sponsors

Posted by Elizabeth Gargill

Catch Up on Our Content for Clinical Trial Sponsors

Now is the perfect time to catch up on our most popular content of 2021!

Featuring insights from industry thought leaders, our content provides clinical trial sponsors with knowledge and guidance to help navigate today’s challenging clinical trial enrollment and engagement landscape.

Read More

Topics: RSG Arrive, Diversity, Inclusion, Decentralized Clinical Trials, Lookbook, Creative Portfolio

Decentralized Clinical Trials

Posted by Elizabeth Gargill

The One Thing Every Sponsor Needs to Start a Decentralized Clinical Trial Off Right

I recently sat down with Chief Innovation Officer Rob Laurens to discuss how BBK's Engagement Solution Center solves many of the challenges sponsors face when planning and initiating a decentralized clinical trial. 

Read More

Topics: Rob Laurens, Engagement Solution Center, Decentralized Clinical Trials, Focus 5, Decentralized Solutions

Cellectar Biosciences Announces Partnership With BBK Worldwide

Posted by Elizabeth Gargill

 

Earlier this week, Cellectar Biosciences, a late-stage clinical biopharmaceutical company focused on the discovery and development of targeted drugs for the treatment of cancer, announced its partnership with BBK to provide concierge services for patients participating in its clinical studies. The services are designed to improve patients' and their caregivers' access to high-quality care and innovative treatments for their cancer.

Read More

Topics: Most Viewed, Concierge Services, Cellectar